CAS 375815-87-5

Varenicline tartrate

Description:

Varenicline tartrate is a pharmacological agent primarily used as a smoking cessation aid. It acts as a partial agonist at nicotinic acetylcholine receptors, which helps to reduce withdrawal symptoms and cravings associated with nicotine addiction. The substance is a white to off-white crystalline powder that is soluble in water, making it suitable for oral administration. Its chemical structure includes a pyridine ring, contributing to its activity at the nicotinic receptors. Varenicline tartrate is typically administered in tablet form and is known for its efficacy in helping individuals quit smoking by mimicking the effects of nicotine while simultaneously blocking its pleasurable effects. Common side effects may include nausea, insomnia, and changes in mood, which necessitate careful monitoring during treatment. As with any medication, it is essential for users to consult healthcare professionals for guidance on its use and potential interactions with other medications.

Formula: C₁₇H₁₉N₃O₆

InChI: InChI=1/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.0/s1

InChI key: InChIKey=TWYFGYXQSYOKLK-LREBCSMRSA-N

SMILES: C1=2C(C3CC1CNC3)=CC=4C(C2)=NC=CN4.[C@@H]([C@H](C(O)=O)O)(C(O)=O)O

Synonyms:

• 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
• 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine (2R,3R)-2,3- dihydroxybutanedioate
• 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline 2,3-dihydroxybutanedioate (1:1)
• Champix
• Cp 526555-18
• Varenicline tartrate
• ChaMpix tartrate
• ,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-
• 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-, (2R,3R)-2,3-dihydroxybutanedioate
• Varenicline tatrate
• Chantix tartrate
• Varenicline tartrate for research
• 7,8,9,10-Tetrahydro-
• 7,8,9,10-Tetrahydro-6H-6,10-methanoazepino-[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate
• Unii-82269asb48
• Varenicline tartrate solution

Varenicline Tartrate

CAS: 375815-87-5

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Purity: >95.0%(T)

Color and Shape: White to Light yellow to Light orange powder to crystal

Molecular weight: 361.35

Ref: 3B-V0168

Varenicline tartrate

CAS: 375815-87-5

Varenicline tartrate

Formula: C₁₇H₁₉N₃O₆

Purity: 98%

Molecular weight: 361.354

Ref: 54-OR1027742

Varenicline Tartrate

CAS: 375815-87-5

Varenicline Tartrate

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Purity: ≥95%

Molecular weight: 361.35

Ref: 54-BUP05997

Varenicline tartrate

CAS: 375815-87-5

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Purity: ≥ 98%

Color and Shape: White to off-white powder or solid

Molecular weight: 361.35

Ref: 7W-GL2009

Varenicline Tartrate

Controlled Product

CAS: 375815-87-5

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Color and Shape: Neat

Molecular weight: 361.35

Ref: 86-MM3380.00

Varenicline Tartrate

CAS: 375815-87-5

7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate

Formula: C₁₇H₁₉N₃O₆

Purity: 98%

Molecular weight: 361.35

Ref: IN-DG157709

Varenicline Tartrate

CAS: 375815-87-5

Varenicline Tartrate (CP 526555-18) is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist.

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Purity: 98.23% - 98.32%

Color and Shape: Solid

Molecular weight: 361.35

Ref: TM-T1657

Varenicline Tartrate

CAS: 375815-87-5

Formula: C₁₃H₁₃N₃C₄H₆O₆

Molecular weight: 211.3 : 150.1

Ref: ST-EA-CP-V8000

Varenicline tartrate

CAS: 375815-87-5

Partial agonist of α4β2 nicotinic receptors; acetylcholine receptor α7 agonist

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 361.35 g/mol

Ref: 3D-FV10829

Varenicline Tartrate

CAS: 375815-87-5

Formula: C₁₃H₁₃N₃·C₄H₆O₆

Color and Shape: Neat

Molecular weight: 361.35

Ref: TR-V098490